Annual FCF:
-$273.69M+$48.59M(+15.08%)Summary
- As of today, TVTX annual free cash flow is -$273.69 million, with the most recent change of +$48.59 million (+15.08%) on December 31, 2024.
- During the last 3 years, TVTX annual free cash flow has fallen by -$234.74 million (-602.79%).
Performance
TVTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$7.34M+$46.64M(+86.41%)Summary
- As of today, TVTX quarterly free cash flow is -$7.34 million, with the most recent change of +$46.64 million (+86.41%) on June 30, 2025.
- Over the past year, TVTX quarterly free cash flow has increased by +$44.90 million (+85.95%).
- TVTX quarterly free cash flow is now -127.49% below its all-time high of $26.69 million, reached on September 30, 2021.
Performance
TVTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$157.30M+$44.90M(+22.21%)Summary
- As of today, TVTX TTM free cash flow is -$157.30 million, with the most recent change of +$44.90 million (+22.21%) on June 30, 2025.
- Over the past year, TVTX TTM free cash flow has increased by +$160.47 million (+50.50%).
Performance
TVTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TVTX Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +15.1% | +86.0% | +50.5% |
3Y3 Years | -602.8% | +84.8% | -37.7% |
5Y5 Years | -271.0% | +32.6% | -195.1% |
TVTX Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -602.8% | +15.1% | at high | +94.2% | at high | +53.5% |
5Y | 5-Year | -602.8% | +15.1% | -127.5% | +94.2% | -436.2% | +53.5% |
All-Time | All-Time | >-9999.0% | +15.1% | -127.5% | +94.2% | >-9999.0% | +53.5% |
TVTX Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$7.34M(+86.4%) | -$157.30M(+22.2%) |
Mar 2025 | - | -$53.98M(-19.2%) | -$202.19M(+26.1%) |
Dec 2024 | -$273.69M(+15.1%) | -$45.28M(+10.7%) | -$273.69M(+10.1%) |
Sep 2024 | - | -$50.70M(+2.9%) | -$304.41M(+4.2%) |
Jun 2024 | - | -$52.24M(+58.4%) | -$317.77M(+6.2%) |
Mar 2024 | - | -$125.47M(-65.1%) | -$338.67M(-5.1%) |
Dec 2023 | -$322.28M(-50.0%) | -$76.00M(-18.6%) | -$322.28M(-5.6%) |
Sep 2023 | - | -$64.06M(+12.4%) | -$305.11M(-5.9%) |
Jun 2023 | - | -$73.13M(+33.0%) | -$288.21M(-9.4%) |
Mar 2023 | - | -$109.08M(-85.4%) | -$263.35M(-22.6%) |
Dec 2022 | -$214.85M(-451.7%) | -$58.84M(-24.8%) | -$214.85M(-14.2%) |
Sep 2022 | - | -$47.16M(+2.3%) | -$188.09M(-64.6%) |
Jun 2022 | - | -$48.27M(+20.3%) | -$114.24M(-79.1%) |
Mar 2022 | - | -$60.59M(-88.9%) | -$63.79M(-63.8%) |
Dec 2021 | -$38.94M(+42.1%) | -$32.08M(-220.2%) | -$38.94M(-32.7%) |
Sep 2021 | - | $26.69M(+1119.2%) | -$29.34M(+47.8%) |
Jun 2021 | - | $2.19M(+106.1%) | -$56.21M(+18.9%) |
Mar 2021 | - | -$35.74M(-59.1%) | -$69.28M(-2.9%) |
Dec 2020 | -$67.31M(+8.8%) | -$22.47M(>-9900.0%) | -$67.31M(-26.3%) |
Sep 2020 | - | -$180.00K(+98.3%) | -$53.31M(+25.4%) |
Jun 2020 | - | -$10.89M(+67.8%) | -$71.47M(+14.0%) |
Mar 2020 | - | -$33.77M(-298.6%) | -$83.08M(-12.6%) |
Dec 2019 | -$73.78M(-65.2%) | -$8.47M(+53.8%) | -$73.78M(-1.4%) |
Sep 2019 | - | -$18.34M(+18.5%) | -$72.74M(-17.0%) |
Jun 2019 | - | -$22.50M(+8.1%) | -$62.14M(-34.7%) |
Mar 2019 | - | -$24.47M(-229.3%) | -$46.14M(-3.3%) |
Dec 2018 | -$44.66M(-576.0%) | -$7.43M(+4.0%) | -$44.66M(-8.9%) |
Sep 2018 | - | -$7.74M(-19.2%) | -$41.02M(-33.1%) |
Jun 2018 | - | -$6.49M(+71.8%) | -$30.82M(-36.9%) |
Mar 2018 | - | -$22.99M(-506.0%) | -$22.50M(-240.7%) |
Dec 2017 | -$6.61M | -$3.79M(-254.0%) | -$6.61M(+52.2%) |
Sep 2017 | - | $2.46M(+35.6%) | -$13.81M(+3.5%) |
Jun 2017 | - | $1.82M(+125.6%) | -$14.31M(+0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | -$7.09M(+35.5%) | -$14.45M(-6.8%) |
Dec 2016 | -$13.52M(-78.3%) | -$10.99M(-662.1%) | -$13.52M(-98.9%) |
Sep 2016 | - | $1.96M(+16.2%) | -$6.80M(+39.3%) |
Jun 2016 | - | $1.68M(+127.3%) | -$11.21M(-75.3%) |
Mar 2016 | - | -$6.17M(-44.3%) | -$6.39M(+15.7%) |
Dec 2015 | -$7.58M(+84.8%) | -$4.27M(-74.3%) | -$7.58M(+39.3%) |
Sep 2015 | - | -$2.45M(-137.7%) | -$12.49M(+51.4%) |
Jun 2015 | - | $6.50M(+188.3%) | -$25.69M(+45.5%) |
Mar 2015 | - | -$7.36M(+19.8%) | -$47.14M(+5.4%) |
Dec 2014 | -$49.81M(-115.3%) | -$9.18M(+41.4%) | -$49.81M(+6.0%) |
Sep 2014 | - | -$15.66M(-4.8%) | -$53.01M(-32.5%) |
Jun 2014 | - | -$14.95M(-49.0%) | -$40.02M(-46.7%) |
Mar 2014 | - | -$10.03M(+18.9%) | -$27.29M(-17.9%) |
Dec 2013 | -$23.14M(-488.8%) | -$12.37M(-363.6%) | -$23.14M(-114.8%) |
Sep 2013 | - | -$2.67M(-20.3%) | -$10.77M(-32.9%) |
Jun 2013 | - | -$2.22M(+62.3%) | -$8.10M(-37.7%) |
Mar 2013 | - | -$5.89M(>-9900.0%) | -$5.89M(>-9900.0%) |
Dec 2012 | -$3.93M(>-9900.0%) | - | - |
Nov 2011 | - | $0.00(0.0%) | -$600.00(+14.3%) |
Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
May 2011 | - | $0.00(+100.0%) | -$700.00(0.0%) |
Feb 2011 | -$700.00(-600.0%) | -$600.00(-500.0%) | -$700.00(-600.0%) |
Nov 2010 | - | -$100.00(>-9900.0%) | -$100.00(>-9900.0%) |
Aug 2010 | - | $0.00(0.0%) | $0.00(+100.0%) |
May 2010 | - | $0.00(0.0%) | -$100.00(0.0%) |
Feb 2010 | -$100.00(+99.5%) | $0.00(0.0%) | -$100.00(0.0%) |
Nov 2009 | - | $0.00(+100.0%) | -$100.00(+66.7%) |
Aug 2009 | - | -$100.00(>-9900.0%) | -$300.00(-50.0%) |
May 2009 | - | $0.00(0.0%) | -$200.00(+99.0%) |
Feb 2009 | -$20.20K(>-9900.0%) | $0.00(+100.0%) | -$20.20K(0.0%) |
Nov 2008 | - | -$200.00(>-9900.0%) | -$20.20K(-1.0%) |
Aug 2008 | - | $0.00(+100.0%) | -$20.00K(0.0%) |
May 2008 | - | -$20.00K | -$20.00K |
Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Travere Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Travere Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Travere Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of TVTX is -$273.69M
What is the all-time high annual free cash flow for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual free cash flow is $0.00
What is Travere Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, TVTX annual free cash flow has changed by +$48.59M (+15.08%)
What is Travere Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of TVTX is -$7.34M
What is the all-time high quarterly free cash flow for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly free cash flow is $26.69M
What is Travere Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, TVTX quarterly free cash flow has changed by +$44.90M (+85.95%)
What is Travere Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of TVTX is -$157.30M
What is the all-time high TTM free cash flow for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM free cash flow is $0.00
What is Travere Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, TVTX TTM free cash flow has changed by +$160.47M (+50.50%)